EnergiseME

EnergiseME Evaluation of the link between auto-immunity and derangements in immune cell metabolism and function in ME/CFS patients

Background

About the study

The researchers hypothesize that antibodies in people with ME/CFS may cause changes in how their blood and certain cells work. These changes in the cells could lead to the symptoms in ME/CFS. To test this idea, they will answer these 3 questions:

  1. What happens to the energy-producing parts of the cells (mitochondria) and how do white blood cells use this energy of ME/CFS patients?
  2. How does auto-immunity connect to problems with how white blood cells use energy?
  3. Could problems with how white blood cells use energy and the auto-immunity lead to the symptoms of ME/CFS?

 

With EnergiseME, researchers will include teenagers who have ME/CFS and add their samples to the NMCB. They will study these samples to understand how their cell’s mitochondria and the way their white blood cells use energy are affected. They will do this by using special imaging tests, studying molecules in the blood, and looking at how things move in the cells. They will also test how certain substances in the blood affect the way some of the patients’ cells work, and how they interact with nerve cells. This will help our understanding of how problems with auto-immunity are connected to how the white blood cells use energy in ME/CFS. To test their ideas, they will transfer antibodies and proteins from ME/CFS patients to mice and will try different ways to change how the mice’s cells make energy. This will show if the antibodies and proteins from ME/CFS patients can really cause problems in the cells and make mice have ME/CFS-like symptoms.

Subproject

Team

Dr. Niels Eijkelkamp

Principal investigator